Major depressive disorder and health care costs in multiple sclerosis

International Journal of Psychiatry in Medicine

Volumn 32, Issue 2, 2002, Pages 167-178

  Patten, Scott B ^a   Jacobs, Philip ^b   Petcu, Ruxandra ^a   Reimer, Marlene A ^a   Metz, Luanne M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Economics; Health care economics and organizations; Health services; Mood disorders; Multiple sclerosis

Indexed keywords

AFFECTIVE NEUROSIS; ARTICLE; DEMYELINATING DISEASE; DEPRESSION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE;

ADULT; AGED; CANADA; DELIVERY OF HEALTH CARE; DEPRESSIVE DISORDER; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 0036375240     PISSN: 00912174     EISSN: None     Source Type: Journal    
DOI: 10.2190/K05D-XER3-WT4Y-FDQV     Document Type: Article

References (22)

1. Schiffer RB, Caine ED, Bamford KA, Levy S. Depressive episodes in patients with multiple sclerosis. American Journal of Psychiatry 1983;140:1498-1500.
2. Minden SL, Orav J, Reich P. Depression in multiple sclerosis. General Hospital Psychiatry 1987;9:426-434.
3. Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z. Mood disorders and multiple sclerosis. Archives of Neurology 1987;44:376-378.
4. Patten SB, Metz LM, Reimer MM. Biopsychosocial correlates of major depression in a multiple sclerosis population. Multiple Sclerosis 2000;6:115-120.
5. Simon GE, VonKorff M, Barlow W. Health care costs of primary care patients with recognized depression. Archives of General Psychiatry 1995;52:850-856.
6. Unutzer J, Patrick DL, Simon G, Grembowski D, Walker E, Rutter C et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study. Journal of the American Medical Association 1997; 277(20):1618-1623.
7. Callahan CM, Hui SL, Nienaber NA, Musick BS, Tierney WM. Longitudinal study of depression and health services use among elderly primary care patients. Journal of the American Geriatric Society 1994;42:833-838.
8. MacFarland BH, Freeborn DK, Mullooly JP, Pope CR. Utlilatization patterns among long-term enrollees in a prepaid group practice health maintenance organization. Medical Care 1985;23(11):1221-1233.
9. Henk HJ, Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW. Medical costs attributed to depression among patients with a history of high medical expenses in a health maintenance organization. Archives of General Psychiatry 1996;53:899-904.
10. Larcombe NA, Wilson PH. An evaluation of cognitive-behaviour therapy for depression in patients with multiple sclerosis. British Journal of Psychiatry 1984;145:366-371.
11. Crawford JD, McIvor GP. Group psychotherapy: benefits in multiple sclerosis. Archives of Physical Medicine and Rehabilitation 1985;66:810-813.
12. Schiffer RB, Wineman NM. Antidepressant pharmacotherapy of depression associated with multiple sclerosis. American Journal of Psychiatry 1990;147(11):1493-1497.
13. Hankin JR, Kessler LG, Goldberg ID, Steinwachs DM, Starfield BH. A longitudinal study of offset in the use of nonpsychiatric services following specialized mental health care. Medical Care 1983;21(11):1099-1110.
14. Wittchen HU. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): A critical review. Journal of Psychiatric Research 1994;28(1):57-84.
15. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J et al. The Composite International Diagnostic Interview. An epidemiological instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry 1988;45:1069-1077.
16. Stata. College Station, TX: Stata Corporation, 2001.
17. Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA. Treatment of depression improves adherence to interferon β-1b therapy for multiple sclerosis. Archives of Neurology 1997;54:531-533.
18. Neilley LK, Goodin DS, Goodkin DE, Hauser SL. Side effect profile of interferon beta-1b in MS: Results of an open label trial. Neurology 1996;46:552-554.
19. Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IML, Eisen K et al. Depression and multiple sclerosis. Neurology 1996;46:628-632.
20. Wang JL, Reimer MA, Metz LM, Patten SB. Major depression and quality of life in individuals with multiple sclerosis. International Journal of Psychiatric Medicine 2000;30:309-317.
21. Stenager EN, Stenager E, Koch-Henriksen N, Bronnum-Hansen H, Hyllested K, Jensen K et al. Suicide and multiple sclerosis: An epidemiological investigation. Journal of Neurology, Neurosurgery and Psychiatry 1992;55:542-545.
22. Mohr DC, Goodkin DE, Likosky W, Gatto N, Neilly LK, Griffin C et al. Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: Relationship to adherence to treatment. Multiple Sclerosis 1996;2:222-226.